Description

Indication & Scope

JiuLian® (Allopurinol Tablets) are indicated for the long-term management of hyperuricemia associated with primary or secondary gout, including recurrent or chronic gout, gouty tophi, and uric acid nephrolithiasis. By reducing uric acid production, allopurinol helps maintain serum urate levels below the target range and prevent further deposition of urate crystals.

Mechanism: Allopurinol and its active metabolite oxypurinol inhibit xanthine oxidase, reducing the conversion of hypoxanthine and xanthine to uric acid and thereby lowering serum and urinary uric acid levels.
Drug class: Xanthine oxidase inhibitor.
Clinical use: Long-term urate-lowering therapy for hyperuricemia and gout, particularly in patients with recurrent gout attacks, tophi, uric acid stones, or other indications for sustained urate reduction.

Specification

Generic Name	Allopurinol Tablets
Brand Name	JiuLian®
Ingredient	Allopurinol
Dosage Form	Tablet
Package	0.1 g/tablet, 20 tablets/blister/box
Conditions Treated	Hyperuricemia associated with primary or secondary gout, including recurrent or chronic gout, gouty tophi, and uric acid nephrolithiasis
Taboos	Hypersensitivity to allopurinol or any component of the product
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store in a tightly closed container in a dry place at room temperature and protect from light.
Manufacturer	Hefei Jiulian Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H34021248
Approval Date	July 4, 2025
Shelf Life	24 months

How to use ?

Recommended Dose: Start at 50–100 mg once daily and gradually increase according to serum urate response and tolerability. Typical maintenance dose is 200–300 mg/day.

Time: Take orally after meals with adequate water.

Instructions for use: Start with a low dose and titrate gradually. Continue treatment during an acute gout attack if already receiving allopurinol; do not initiate urate-lowering therapy solely to treat acute pain.

Interaction: Allopurinol markedly increases exposure to azathioprine and mercaptopurine and their doses generally require substantial reduction. Thiazide diuretics may increase the risk of hypersensitivity. Concomitant ampicillin or amoxicillin may increase the incidence of rash.

Side effects: Common reactions include rash, gastrointestinal discomfort, diarrhea, and elevated liver enzymes. Serious hypersensitivity reactions, including Stevens–Johnson syndrome, toxic epidermal necrolysis, and DRESS, may occur.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is JiuLian®?

JiuLian® contains allopurinol, a xanthine oxidase inhibitor that reduces uric acid production.

What is it used for?

It is used for long-term urate-lowering treatment of hyperuricemia and gout.

How should this medicine be started?

Treatment should generally begin at a low dose and be gradually increased according to serum urate levels and tolerability.

Can it be stopped during an acute gout attack?

Patients already taking it generally should not discontinue it solely because an acute attack occurs. Anti-inflammatory treatment is used to manage the acute attack.